How to Read a Peptide COA

Start with sample identity, not the headline number

Begin at the report header. Record the stated compound or material name, batch or lot number, sample identifier, report number, and the organization that submitted or produced the sample. Then compare those identifiers with the vial label, receiving record, and catalog record. A technically detailed report cannot be assigned to a vial when the lot connection is missing or ambiguous.

Check whether the certificate describes a finished batch, a submitted sample, a reference material, or another material type. Those scopes are not interchangeable. Also note the test date, issue date, and any revision number. A later amended report should be distinguished from the original rather than silently replacing it in laboratory records.

• Material or compound name
• Batch, lot, or sample identifier
• Report or certificate number
• Testing laboratory and requesting organization
• Receipt, test, approval, and issue dates when supplied
• Version, amendment, or superseded-report status

Read the results table as a set of linked fields

A result should be interpreted as a row, not as an isolated value. The row normally connects a test name, analytical procedure, acceptance criterion or specification, observed result, and unit. If a certificate says only “purity: 99%” without defining the procedure or reporting basis, the reader cannot determine what population of material the percentage describes.

Separate a specification from a result. A specification is the pre-established criterion against which a result is evaluated; it is not evidence that the batch achieved that value. Words such as conforms, passes, or within specification should still be traceable to a stated method and criterion. Qualitative identity results and quantitative purity results also answer different questions.

Distinguish identity, purity, assay, and supporting attributes

Identity testing asks whether the measured material is consistent with the stated compound under the selected technique. Chromatographic purity estimates the relative signal assigned to the main component versus detected peaks under a defined chromatographic method. Assay or content testing estimates how much target material is present using a stated calculation and, commonly, an appropriate reference. These terms should not be collapsed into a single concept.

Water, residual solvents, counterions, elemental impurities, microbiological attributes, and appearance may require separate procedures. Whether any of these belong on a batch specification depends on the material, research purpose, risk assessment, and applicable laboratory protocol. The absence of a test on a COA means that the certificate does not report that attribute; it should not be read as a zero result.

Review a chromatogram without over-reading it

When an HPLC chromatogram is attached, confirm that its sample identifier and acquisition information correspond to the certificate. Look for labeled axes, retention times, detector channel or wavelength, integration markers, and a peak table. The main peak is usually the largest detector response under those conditions, but size alone does not prove molecular identity.

An area-percent calculation typically divides an integrated peak area by the total integrated area included in the calculation. It may exclude unintegrated regions or signals the detector does not adequately observe, and two substances can sometimes overlap. A chromatogram is therefore evidence within a method, not a photograph of every component in the vial. Read the HPLC method and any complementary identity result together.

• Does the chromatogram carry the same sample or lot identifier?
• Are detector settings and the analytical method named?
• Are integration boundaries and excluded peaks explained?
• Does the report distinguish retention-time agreement from identity confirmation?

Check method context and system suitability

A defensible result depends on a procedure that is fit for its stated purpose. Useful context may include the method identifier and revision, column chemistry, mobile phases, gradient, flow rate, detector, reference standard, calculation, and system-suitability criteria. A COA does not always reproduce the full controlled method, but it should identify the method clearly enough for the result to be understood and retrieved.

ICH Q2(R2) frames validation characteristics according to the purpose of the analytical procedure. FDA guidance likewise emphasizes documented analytical procedures and validation data in its regulated scope. These documents are useful analytical-literacy references; citing them does not mean a particular vendor, material, or laboratory is operating under an FDA application or ICH program.

Evaluate traceability and report authenticity

Traceability is a documented chain, not a logo. Review the laboratory identity, report identifier, authorization or approval field, contact or verification route, and any statement about standards used. NIST explains that traceability attaches to a measurement result through a documented, unbroken chain and does not automatically transfer merely because an instrument or reference is associated with NIST.

For an online certificate, use the site’s COA record to compare the displayed batch, report number, dates, and document version. Save the verification date in the project record when that matters to the laboratory. If a report has been corrected, preserve the audit relationship between versions.

Common red flags and what a COA cannot establish

Investigate a missing lot number, conflicting sample names, a result without units, an unexplained method label, a cropped screenshot in place of a report, mismatched dates, or a percentage with no reporting basis. None proves that a result is wrong, but each interrupts the evidence chain and calls for clarification before the certificate is relied upon.

Even a complete COA is limited to the sampled material, listed procedures, reported dates, and stated acceptance criteria. It does not by itself demonstrate ongoing stability, container integrity after shipment, sterility, absence of every possible impurity, or suitability for an unstated purpose. It never converts a research-use-only material into a product intended for use in humans or animals.